Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of the Nativis Voyager® System in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM)

NCT03276286 is registered in ClinicalTrials.gov with Nativis, Inc. as lead sponsor.

NCT NCT03276286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03276286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of the Nativis Voyager® System in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM)
Lead sponsor
Nativis, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 10, 2017
Completion date
May 31, 2022
Enrollment
37 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme